Filing Details

Accession Number:
0001628280-24-037559
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-16 16:18:22
Reporting Period:
2024-08-14
Accepted Time:
2024-08-16 16:18:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1723128 Amneal Pharmaceuticals Inc. AMRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239546 S Andrew Boyer C/O Amneal Pharmaceuticals, Inc.
Bridgewater NJ 08807
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2024-08-14 22,486 $7.81 296,895 No 4 S Direct
Class A Common Stock Disposition 2024-08-15 40,225 $7.85 256,670 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.84 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.92 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.